R. Jackson

发表

Aspirin inhibits vasopressin-induced hypothalamic-pituitary-adrenal activity in normal humans.

D. Torpy, J. Grice, G. Hockings, 1997, The Journal of clinical endocrinology and metabolism.

Paradoxical inhibition by aspirin of naloxone-induced adrenocorticotropin secretion in myotonic dystrophy.

D. Torpy, J. Grice, G. Hockings, 1994, The Journal of clinical endocrinology and metabolism.

DOSE RESPONSE OF PLASMA ADRENOCORTICOTROPIN AND CORTISOL

W. Vale, J. Rivier, C. Rivier, 1983 .

Effect of synthetic ovine corticotropin-releasing factor: Prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol

W. Vale, J. Rivier, D. Orth, 1984 .

Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor.

W. Vale, J. Rivier, D. Orth, 1984, The Journal of clinical investigation.

Rapid sequential intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjects.

M. Thorner, D. Orth, W. Sheldon, 1985, The Journal of clinical endocrinology and metabolism.

Effect of synthetic ovine corticotropin-releasing factor: prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol.

W. Vale, J. Rivier, D. Orth, 1983, The Journal of clinical endocrinology and metabolism.

Clinical studies with synthetic ovine corticotropin-releasing factor.

J. Rivier, W. Nicholson, D. Orth, 1985, Federation proceedings.

Effect of subcutaneous and intranasal administration of ovine corticotropin-releasing hormone in man: comparison with intravenous administration.

W. Nicholson, D. Orth, W. Sheldon, 1985, The Journal of clinical endocrinology and metabolism.

Plasma distribution, disappearance half-time, metabolic clearance rate, and degradation of synthetic ovine corticotropin-releasing factor in man.

W. Vale, J. Rivier, W. Nicholson, 1983, The Journal of clinical endocrinology and metabolism.

The effects of dietary fibre on glucose tolerance in healthy males.

M. Wahlqvist, G. Littlejohn, M. Morris, 1979, Australian and New Zealand journal of medicine.

Different norepinephrine disappearance rate in venous and arterial plasma in man.

A. Bachmann, R. Gordon, R. Jackson, 1983, Clinical and experimental hypertension. Part A, Theory and practice.

Pituitary and hypothalamic hormones in normal and neoplastic adrenal medullae: biologically active corticotropin-releasing hormone and corticotropin

W. Nicholson, D. Orth, R. Jackson, 1987, Regulatory Peptides.

Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.

D. Orth, W. Sheldon, C. Debold, 1989, The Journal of clinical endocrinology and metabolism.

Synthetic ovine corticotropin-releasing hormone: simultaneous release of proopiolipomelanocortin peptides in man.

W. Vale, J. Rivier, D. Orth, 1984, The Journal of clinical endocrinology and metabolism.

Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.

J. Grice, G. Hockings, E. J. Nye, 1999, The Journal of clinical endocrinology and metabolism.

SGLT2-Inhibitor induced euglycemic ketoacidosis in acute surgical patients

A. M. Hawkins, R. Jackson, D. Vardesh, 2017 .

Interactions Between the Stimulated Hypothalamic‐Pituitary‐Adrenal Axis and Leptin in Humans

D. Torpy, J. Grice, G. Hockings, 2000, Journal of neuroendocrinology.

Effect of ovine corticotropin-releasing hormone administered during insulin-induced hypoglycemia on plasma adrenocorticotropin and cortisol.

D. Orth, W. Sheldon, C. Debold, 1987, The Journal of clinical endocrinology and metabolism.

The Insulin Hypoglycemia Test: Hypoglycemic Criteria and Reproducibility

D. Torpy, J. Grice, G. Hockings, 2001, Journal of neuroendocrinology.

Letter to the Editor: Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change A Letter to the Editor in response to J.C. Preussner et al. (2003) Psychoneuroendocrinology 28, 916-931.

J. Grice, R. Jackson, 2004, Psychoneuroendocrinology.

Relationship of renal hemodynamic and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dog.

R. Jackson, R. Workman, M. Shaff, 1983, Investigative radiology.

INCREASED PLASMA NORADRENALINE DURING LOW DOSE ADRENALINE INFUSION IN RESTING MAN AND DURING SYMPATHETIC STIMULATION

A. Bachmann, R. Gordon, I. Musgrave, 1985, Clinical and experimental pharmacology & physiology.

New Genetic Insights in Familial Hyperaldosteronism

C. Stratakis, D. Torpy, A. Lafferty, 2002, Annals of the New York Academy of Sciences.

NALOXONE‐INDUCED ACTH RELEASE IN MAN IS INHIBITED BY CLONIDINE

J. Grice, G. Hockings, R. Jackson, 1990, Clinical and experimental pharmacology & physiology.

Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.

D. Torpy, J. Grice, G. Hockings, 1993, The Journal of clinical endocrinology and metabolism.

Glucocorticoid receptor polymorphisms and post-traumatic stress disorder

Teresa L. Sedgley, R. Young, D. Torpy, 2005, Psychoneuroendocrinology.

Adrenocorticotropin Hyperresponsiveness in Myotonic Dystrophy Following Oral Fenfluramine Administration

J. Grice, R. Jackson, P. Penfold, 1991, Journal of neuroendocrinology.

Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor.

W. Vale, J. Rivier, C. Rivier, 1982, The Journal of clinical endocrinology and metabolism.

Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.

W. Nicholson, D. Orth, W. Sheldon, 1996, The Journal of clinical endocrinology and metabolism.

Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol.

W. Vale, J. Rivier, C. Rivier, 1983, The Journal of clinical investigation.

Naloxone‐induced ACTH release: mechanism of action in humans

D. Torpy, J. Grice, G. Hockings, 1995, Clinical endocrinology.

Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.

J. Grice, G. Hockings, M. Walters, 1993, The Journal of clinical endocrinology and metabolism.

NALOXONE STIMULATION OF ACTH SECRETION DURING PETROSAL SINUS SAMPLING IN CUSHING'S SYNDROME

D. Torpy, J. Grice, G. Hockings, 1993, Clinical and experimental pharmacology & physiology.

Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.

D. Torpy, J. Grice, G. Hockings, 1994, The Journal of clinical endocrinology and metabolism.

EFFECT OF FLUMAZENIL ON BASAL AND NALOXONE‐STIMULATED ACTH AND CORTISOL RELEASE IN HUMANS

D. Torpy, J. Grice, G. Hockings, 1994, Clinical and experimental pharmacology & physiology.

Long term minoxidil therapy and renal function, cardiac function, hypertrichosis and blood pressure.

R. Gordon, M. Williamson, R. Jackson, 1983, Australian and New Zealand journal of medicine.

DIURNAL EFFECTS OF FLUOXETINE AND NALOXONE ON THE HUMAN HYPOTHALAMIC‐PITUITARY‐ADRENAL AXIS

D. Torpy, J. Grice, G. Hockings, 1997, Clinical and experimental pharmacology & physiology.

The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.

D. Torpy, J. Grice, G. Hockings, 1995, The Journal of clinical endocrinology and metabolism.

Effect of Exogenous Arginine Vasopressin on Adrenocorticotropin and Cortisol Release in Myotonie Dystrophy Patients: Delayed Responses of Normal Magnitude

J. Grice, R. Jackson, P. Penfold, 1991, Journal of neuroendocrinology.

POTENTIATION OF FENFLURAMINE‐INDUCED ACTH RELEASE IN MAN BY NALOXONE

J. Grice, R. Jackson, A. J. Jackson, 1989, Clinical and experimental pharmacology & physiology.

Renin exists in human adrenal tissue.

C. Sussman, T. Inagami, R. Jackson, 1983, The Journal of clinical endocrinology and metabolism.

Increased sympathetic activity in renovascular hypertension in man.

A. Bachmann, R. Gordon, R. Jackson, 1982, Clinical and experimental pharmacology & physiology.

Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.

D. Torpy, R. Azziz, L. Fox, 1998, The Journal of clinical endocrinology and metabolism.

Use of a microprocessor in the control of malignant hypertension with sodium nitroprusside.

J B Love, M. Wahlqvist, M L Wahlqvist, 1977, Australian and New Zealand journal of medicine.

Adrenocorticotropin stimulation tests in patients with hypothalamic‐pituitary disease: low dose, standard high dose and 8‐h infusion tests

D. Torpy, J. Grice, G. Hockings, 2001, Clinical endocrinology.

NIFEDIPINE BLOCKS ACTH AND CORTISOL RELEASE IN MAN

J. Grice, R. Jackson, A. J. Jackson, 1989, Clinical and experimental pharmacology & physiology.

Hypersensitivity of the hypothalamic-pituitary-adrenal axis to naloxone in post-traumatic stress disorder

J. Grice, G. Hockings, M. Walters, 1993, Biological Psychiatry.

Familial corticosteroid-binding globulin deficiency due to a novel null mutation: association with fatigue and relative hypotension.

J. Whitworth, D. Torpy, A. Bachmann, 2001, The Journal of clinical endocrinology and metabolism.

Aldosterone producing adenoma: fludrocortisone suppression and left adrenal vein catheterisation in definitive diagnosis and management.

R. Gordon, R. Jackson, T. Tunny, 1979, Australian and New Zealand journal of medicine.

FACTORS AFFECTING THE FREQUENCY OF OCCURRENCE OF SPIRONOLACTONE BODIES IN ALDOSTERONOMAS AND NON‐TUMOROUS CORTEX

R. Gordon, R. Jackson, D. Cohn, 1983, Pathology.

IDIOPATHIC ALDOSTERONISM: DIAGNOSTIC ARTIFACT?

R. Jackson, RichardD. Gordon, 1980, The Lancet.

EFFECT OF SODIUM VALPROATE ON NALOXONE‐STIMULATED ACTH AND CORTISOL RELEASE IN HUMANS

D. Torpy, J. Grice, G. Hockings, 1995, Clinical and experimental pharmacology & physiology.

Association Between Chronic Fatigue Syndrome and the Corticosteroid‐Binding Globulin Gene ALA SER224 Polymorphism

J. M. Harris, S. Easteal, J. Whitworth, 2004, Endocrine research.

A synergistic adrenocorticotropin response to naloxone and vasopressin in normal humans: evidence that naloxone stimulates endogenous corticotropin-releasing hormone.

D. Torpy, J. Grice, G. Hockings, 1995, Neuroendocrinology.

Adrenocorticotropin hyperresponse to the corticotropin-releasing hormone-mediated stimulus of naloxone in patients with myotonic dystrophy.

D. Torpy, J. Grice, G. Hockings, 1995, The Journal of clinical endocrinology and metabolism.

Altered hypothalamic-pituitary-adrenal axis responsiveness in myotonic dystrophy: in vivo evidence for abnormal dihydropyridine-insensitive calcium transport.

J. Grice, G. Hockings, M. Walters, 1993, Journal of Clinical Endocrinology and Metabolism.

Increased pro-opiomelanocortin-derived peptide release in myotonic dystrophy.

C. Sussman, A. Atkinson, W. Nicholson, 1988, Australian paediatric journal.

The use of naloxone for investigating disorders of the hypothalamic-pituitary-adrenal axis

D. Torpy, J. Grice, E. J. Nye, 1999 .

Diurnal variation in the response of plasma adrenocorticotropin and cortisol to intravenous ovine corticotropin-releasing hormone.

D P Island, D. Orth, W. Sheldon, 1985, The Journal of clinical endocrinology and metabolism.

Unstimulated renal venous renin ratio predicts improvement in hypertension following nephrectomy for unilateral renal disease.

R. Gordon, R. Jackson, T. Tunny, 1986, Nephron.

Cell‐mediated immunity in combat veterans with post‐traumatic stress disorder

J. Grice, R V Jackson, R. Jackson, 1994, The Medical journal of Australia.

Polyneuropathy in Australian outpatients with type II diabetes mellitus.

R. Jackson, J. Joyner, C. Strakosch, 1999, Journal of diabetes and its complications.